Patients in the CHD with T2DM group had higher RBP4 levels compared to the CHDwithout T2DM group (49.26 ± 19.70 vs. 34.67 ± 7.78, p <0.001), Fig. 4a. This evidence concerns the gene RBP4 and coronary artery disorder.